Syndax Pharmaceuticals (SNDX) Q2 2025 Earnings

May 5Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.25
-1.1
-0.95
-0.8

Details

Expected EPS
-1.252412
Actual EPS
-0.98
Surprise EPS
0.27
Surprise Percent
+21.75%

Description

⁨Syndax Pharmaceuticals⁩ (⁦SNDX⁩) has reported earnings of ⁦-0.98⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts